ATE202476T1 - Pharmazeutische zusammensetzungen mit verbesserter perkutaner absorption für piroxicam - Google Patents

Pharmazeutische zusammensetzungen mit verbesserter perkutaner absorption für piroxicam

Info

Publication number
ATE202476T1
ATE202476T1 AT94903120T AT94903120T ATE202476T1 AT E202476 T1 ATE202476 T1 AT E202476T1 AT 94903120 T AT94903120 T AT 94903120T AT 94903120 T AT94903120 T AT 94903120T AT E202476 T1 ATE202476 T1 AT E202476T1
Authority
AT
Austria
Prior art keywords
absorption
piroxicam
pharmaceutical compositions
percutane
improved
Prior art date
Application number
AT94903120T
Other languages
English (en)
Inventor
Dong Son Min
Kee An Um
Yong Soo Kim
Pyeong Uk Park
Key Hyup Kim
Ho Seung Yang
Hey Soon Jeong
Mi Young Park
Original Assignee
Sunkyong Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sunkyong Ind Ltd filed Critical Sunkyong Ind Ltd
Application granted granted Critical
Publication of ATE202476T1 publication Critical patent/ATE202476T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061Polyacrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT94903120T 1992-12-31 1993-12-31 Pharmazeutische zusammensetzungen mit verbesserter perkutaner absorption für piroxicam ATE202476T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR920027130 1992-12-31
PCT/KR1993/000127 WO1994015609A1 (en) 1992-12-31 1993-12-31 Enhanced pharmaceutical compositions for skin penetration

Publications (1)

Publication Number Publication Date
ATE202476T1 true ATE202476T1 (de) 2001-07-15

Family

ID=19348264

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94903120T ATE202476T1 (de) 1992-12-31 1993-12-31 Pharmazeutische zusammensetzungen mit verbesserter perkutaner absorption für piroxicam

Country Status (13)

Country Link
US (1) US5916587A (de)
EP (1) EP0676962B9 (de)
JP (1) JP2847578B2 (de)
KR (1) KR100212961B1 (de)
AT (1) ATE202476T1 (de)
AU (2) AU5718494A (de)
BR (1) BR9307754A (de)
CA (1) CA2153166A1 (de)
DE (1) DE69330388T2 (de)
ES (1) ES2160623T3 (de)
PT (1) PT676962E (de)
RU (1) RU2110261C1 (de)
WO (1) WO1994015609A1 (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3382032B2 (ja) 1994-10-14 2003-03-04 埼玉第一製薬株式会社 インドメタシン貼付剤
DE19526864A1 (de) * 1995-07-22 1997-01-23 Labtec Gmbh Hormonpflaster
KR980000439A (ko) * 1996-06-28 1998-03-30 김준웅 케토프로펜 경피투여 시스템
EP1158967B1 (de) * 1999-03-01 2003-04-16 Amarin Technologies S.A. Transdermales system enthaltend nicht-steroidische entzündungshemmer in einer acrylpolymer-klebematrix
KR100393478B1 (ko) * 2000-03-29 2003-08-06 주식회사종근당 자가유화 매트릭스형 경점막·경피흡수제제
US6455067B1 (en) * 2000-05-24 2002-09-24 Sang-A Pharmaceutical Co., Ltd. Transdermal patch for nonsteroidal antiinflammatory drug(s)
USRE44145E1 (en) 2000-07-07 2013-04-09 A.V. Topchiev Institute Of Petrochemical Synthesis Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
ES2331302T3 (es) 2001-05-01 2009-12-29 A.V. Topchiev Institute Of Petrochemical Synthesis Composiciones de hidrogel.
US8541021B2 (en) 2001-05-01 2013-09-24 A.V. Topchiev Institute Of Petrochemical Synthesis Hydrogel compositions demonstrating phase separation on contact with aqueous media
US20050113510A1 (en) 2001-05-01 2005-05-26 Feldstein Mikhail M. Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components
US20050215727A1 (en) 2001-05-01 2005-09-29 Corium Water-absorbent adhesive compositions and associated methods of manufacture and use
EP1390084B1 (de) 2001-05-01 2011-03-23 A.V. Topchiev Institute of Petrochemical Synthesis Zweiphasige, wasserabsorbierende bioadhäsive zusammenstezung
RU2276177C2 (ru) * 2001-05-01 2006-05-10 Институт Нефтехимического Синтеза Имени А.В. Топчиева Российской Академии Наук Получение гидрофильных, чувствительных к давлению адгезивов с оптимизированными адгезионными свойствами
US8840918B2 (en) 2001-05-01 2014-09-23 A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences Hydrogel compositions for tooth whitening
US8206738B2 (en) 2001-05-01 2012-06-26 Corium International, Inc. Hydrogel compositions with an erodible backing member
DE10141650C1 (de) 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
US20030175329A1 (en) * 2001-10-04 2003-09-18 Cellegy Pharmaceuticals, Inc. Semisolid topical hormonal compositions and methods for treatment
US20030124174A1 (en) * 2001-10-25 2003-07-03 Endo Pharmaceuticals, Inc Method for treating non-neuropathic pain
CA2453013C (en) * 2002-12-13 2011-02-15 Gary W. Cleary Dermal, transdermal, mucosal or transmucosal ingredient delivery devices
EP1648363B1 (de) * 2003-07-03 2019-03-06 Corium International, Inc. Wundverband, vorrichtung zur inhaltsstoffzuführung und iv-hold-down sowie verfahren im zusammenhang damit
JP4626202B2 (ja) * 2003-07-16 2011-02-02 大正製薬株式会社 ピロキシカム含有外用消炎鎮痛剤組成物
KR100552650B1 (ko) * 2003-11-17 2006-02-20 아이큐어 주식회사 피록시캄 함유 소염진통용 플라스터
RU2380092C2 (ru) 2004-01-30 2010-01-27 Кориум Интернэшнл, Инк. Быстро растворяющаяся пленка для доставки активного агента
WO2005123046A1 (en) * 2004-06-15 2005-12-29 Amorepacific Corporation Novel transdermal preparation and its producing method
EP1791575B1 (de) * 2004-08-05 2014-10-08 Corium International, Inc. Klebstoffzusammensetzung
CN102225046A (zh) * 2005-08-05 2011-10-26 努沃研究公司 透皮释药剂型
KR101402592B1 (ko) * 2006-03-06 2014-06-17 에스케이바이오팜 주식회사 피록시캄-무기물 복합체를 포함하는 경피투여 조성물 및이를 이용한 패치시스템
KR101304982B1 (ko) * 2006-05-08 2013-09-06 (주)아모레퍼시픽 경피흡수용 조성물 및 이로부터 형성된 고분자 매트릭스함유 경피흡수제제
WO2008001204A2 (en) * 2006-06-29 2008-01-03 Antares Pharma Ipl Ag Transdermal compositions of pramipexole having enhanced permeation properties
KR100835074B1 (ko) * 2006-09-27 2008-06-03 조선대학교산학협력단 멜록시캄 경피 흡수제 조성물 및 그의 제조 방법
WO2010083035A2 (en) 2009-01-14 2010-07-22 Corium International, Inc. Transdermal administration of tamsulosin
US8563031B2 (en) 2010-05-27 2013-10-22 Absize, Inc. Piroxicam-containing matrix patches and methods for the topical treatment of acute and chronic pain and inflammation therewith
JP5966261B2 (ja) * 2010-06-17 2016-08-10 大正製薬株式会社 外用組成物
EP2794793B1 (de) * 2011-12-21 2018-11-28 3M Innovative Properties Company Klebepflasteranordnung mit überzug sowie system und verfahren zu ihrer herstellung
KR101365321B1 (ko) * 2012-05-22 2014-02-20 제일약품주식회사 매트릭스내 비스테로이드성 소염진통제의 농도구배를 이용하여 경피투과도를 향상시킨 패취제
KR102009546B1 (ko) 2012-06-20 2019-08-09 히사미쓰 세이야꾸 가부시키가이샤 첩부제
JP6341091B2 (ja) 2012-10-17 2018-06-13 味の素株式会社 化粧料組成物
CA2908041C (en) 2013-04-04 2018-05-01 Hyundai Pharm Co., Ltd. Composition for external use preparation with improved transdermal permeability
DE102014102400A1 (de) * 2014-02-25 2015-08-27 Reinhard Caliebe Topische kosmetische oder pharmazeutische Zusammensetzung
EP3169318B1 (de) * 2014-07-18 2020-04-01 Buzzz Pharmaceuticals Limited Gegen missbrauch gesichertes transdermales system
KR102358377B1 (ko) 2016-12-28 2022-02-03 히사미쓰 세이야꾸 가부시키가이샤 첩부제
TWI781370B (zh) * 2019-01-31 2022-10-21 日商久光製藥股份有限公司 貼附劑
KR20210133821A (ko) 2020-04-29 2021-11-08 신신제약 주식회사 피록시캄을 함유하는 경피 흡수 제제
US11872320B2 (en) 2021-02-25 2024-01-16 Hisamitsu Pharmaceutical Co., Inc. Method for treating osteoarthritis

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2314731A1 (fr) * 1975-06-19 1977-01-14 Nelson Res & Dev Azacycloalcan-2-ones 1-substituees et compositions pharmaceutiques contenant ces composes a titre d'excipients
US4440777A (en) * 1981-07-07 1984-04-03 Merck & Co., Inc. Use of eucalyptol for enhancing skin permeation of bio-affecting agents
US4557934A (en) * 1983-06-21 1985-12-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
DE3586707T2 (de) * 1984-10-05 1993-02-11 Hercon Lab System zur transdermalen applikation eines arzneimittels.
US5196410A (en) * 1986-10-31 1993-03-23 Pfizer Inc. Transdermal flux enhancing compositions
MY102980A (en) * 1986-10-31 1993-03-31 Pfizer Transdermal flux enhancing compositions
JPH0744940B2 (ja) * 1986-12-24 1995-05-17 ライオン株式会社 口腔貼付用基材
US4906475A (en) * 1988-02-16 1990-03-06 Paco Pharmaceutical Services Estradiol transdermal delivery system
ATE80313T1 (de) * 1988-02-29 1992-09-15 Pfizer Mittel zur erhoehung des transdermalen penetrationsflusses.
US5234957A (en) * 1991-02-27 1993-08-10 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5082866A (en) * 1988-06-01 1992-01-21 Odontex, Inc. Biodegradable absorption enhancers
DE58906975D1 (de) * 1988-08-02 1994-03-24 Ciba Geigy Mehrschichtiges Pflaster.
MX21452A (es) * 1989-07-07 1994-01-31 Ciba Geigy Ag Preparaciones farmaceuticas que se administran en forma topica.
US5262165A (en) * 1992-02-04 1993-11-16 Schering Corporation Transdermal nitroglycerin patch with penetration enhancers
JP2820306B2 (ja) * 1990-02-27 1998-11-05 積水化学工業株式会社 経皮吸収製剤

Also Published As

Publication number Publication date
PT676962E (pt) 2001-10-30
DE69330388D1 (de) 2001-08-02
AU2618797A (en) 1997-09-04
KR100212961B1 (ko) 1999-08-02
JPH08500365A (ja) 1996-01-16
AU706123B2 (en) 1999-06-10
BR9307754A (pt) 1995-10-24
EP0676962A1 (de) 1995-10-18
US5916587A (en) 1999-06-29
DE69330388T2 (de) 2002-01-03
RU2110261C1 (ru) 1998-05-10
WO1994015609A1 (en) 1994-07-21
ES2160623T3 (es) 2001-11-16
EP0676962B1 (de) 2001-06-27
AU5718494A (en) 1994-08-15
JP2847578B2 (ja) 1999-01-20
CA2153166A1 (en) 1994-07-21
EP0676962B9 (de) 2002-04-03
KR940013496A (ko) 1994-07-15

Similar Documents

Publication Publication Date Title
DE69330388D1 (de) Pharmazeutische zusammensetzungen mit verbesserter perkutaner absorption für piroxicam
PT99749A (pt) Processo de preparacao de uma composicao incrementadora da permeacao na pele
FI905718A0 (fi) Transdermalt medel.
EA199900553A1 (ru) Чрескожная терапевтическая система
AU7396294A (en) Incorporating poly-n-vinyl amide in a transdermal system
DK0971705T3 (da) Lægemiddelformuleringer til hormonerstatningsterapi til lokal påföring på huden
ES2152979T3 (es) Sistema terapeutico transdermal que contiene estradiol.
FI914391A0 (fi) Sammansaettningar vilka foerstaerker hudens permeabilitet.
DK0901368T3 (da) Dermale gennemtrængningsenhancere og lægemiddeladministrationssystemer, der involverer samme
BR9712304A (pt) Uso de derivados de pirazol1-benzil-3-(hetarila substituìda)-fundidos
ES2184801T3 (es) Preparacion de parche transdermico de tipo de matriz.
UA41446C2 (uk) Застосування фумагілолу та його похідних для одержання ліків, призначених для боротьби з кишковими інфекціями, та фармацевтична композиція на їх основі
DK0922453T3 (da) Tulobuterolholdigt præparat til perkutan absorption
BR0308613A (pt) Combinação de compostos orgânicos
YU45301A (sh) Sistemi za oslobađanje leka kroz kožu
KR850004389A (ko) 경피침투가 증진된 생리학적 활성제제의 제조방법
YU14394A (sh) Flaster sa aktivnom supstancom za davanje estradiola na kožu
DE3866408D1 (de) Selbstklebende vorrichtung zur transdermalen verabreichung eines wirkstoffs.
ATE262333T1 (de) Scopolaminpflaster
ATE285212T1 (de) Absorptionsförderer für topische pharmazeutische formulierungen
PT1152751E (pt) Sistema terapeutico transdermal de desoxipeganina
ATE187776T1 (de) Chemische verbindungen und pharmazeutische zusammensetzungen zur freisetzung von arzneimitteln
YU3390A (sh) Postupak za izradu površinskog terapijskog sistema sa sadržajem antineoplastične aktivne materije, naročito 5-fluor-uracila
ATE61522T1 (de) Pharmazeutische zubereitung zur behandlung von tinea pedis.
DE3881254D1 (de) Pharmazeutische zusammensetzung.